Abeona Therapeutics Inc vs ACM Research Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while ACM Research Inc trades at $81.9 (market cap $5.57B). The key difference: ACM Research Inc is far larger — about 13.2× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, ACM Research Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | ACMR | |
|---|---|---|
Market Cap | $421.19M | $5.57B |
Sector | Health | Technology |
52-Week High | $7.45 | $126.89 |
52-Week Low | $4.17 | $24.93 |
Enterprise Value | $276.10M | $4.48B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →ACM Research develops and manufactures semiconductor process equipment, specializing in wafer cleaning and electroplating solutions. Its tools are used by global chipmakers to improve productivity and yield for logic and memory chips.
Read more on ACMR →